A Study to Evaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines.
NCT05167253
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Regulatory issues raised by the regulatory authority in Taiwan.
Conditions
COVID-19
Interventions
BIOLOGICAL:
UB-612
Sponsor
United Biomedical Inc., Asia